Table 2 Baseline characteristics of NAFLD patients with and without CVD.

From: Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases

Variables

Total

N = 3129

No-CVD N = 2406

CVD

N = 723

P value

Gender*

   

0.003

Male

2419 (77.31%)

1890 (78.55%)

529 (73.17%)

 

Female

710 (22.69%)

516 (21.45%)

194 (26.83%)

 

Age(years)*#

43.35 ± 11.07

42.24 ± 10.48

47.02 ± 12.15

<0.001

< 40

1084 (34.64%)

913 (37.9%)

171 (23.65%)

 

40–49

1339 (42.79%)

1039 (43.18%)

300 (41.49%)

 

50–59

407 (13.01%)

290 (12.05%)

117 (16.18%)

 

60–69

222 (7.09%)

123 (5.11%)

99 (13.69%)

 

≥ 70

77 (2.46%)

41 (1.70%)

36 (4.98%)

 

Diabetes*

259 (8.28%)

162 (6.73%)

97 (13.42%)

< 0.001

Pre-diabetes*

610 (19.50%)

448 (18.62%)

162 (22.41%)

0.028

BMI(kg/m²)*#

25.30 ± 2.83

25.11 ± 2.79

25.91 ± 2.87

<0.001

<24

1033 (33.01%)

846 (35.16%)

187 (25.86%)

 

24–28

1591 (50.85%)

1210 (50.29%)

381 (52.70%)

 

≥ 28

505 (16.14%)

350 (14.54%)

155 (21.44%)

 

WC(cm)*#

88.20 ± 8.52

87.89 ± 8.54

89.22 ± 8.38

<0.001

Normal

1444 (46.15%)

1163 (48.34%)

281 (38.87%)

 

Abnormal

1685 (53.85%)

1243 (51.66%)

442 (61.13%)

 

SBP(mmHg)#

120.02 ± 11.49

118.58 ± 11.56

124.80 ± 9.83

<0.001

DBP(mmHg)#

75.97 ± 7.61

75.02 ± 7.53

79.16 ± 6.96

<0.001

BP(mmHg)*

   

<0.001

<110/75

439 (14.03%)

397 (16.50%)

42 (5.81%)

 

110~<120/75~<80

710 (22.69%)

615 (25.56%)

95 (13.14%)

 

120~<130/80~<85

1055 (33.72%)

813 (33.79%)

242 (33.47%)

 

130~<140/85~<90

925 (29.56%)

581 (24.15%)

344 (47.58%)

 

TC(mmol/L)*#

4.82 ± 0.91

4.78 ± 0.89

4.95 ± 0.97

<0.001

Normal

2891 (92.39%)

2239 (93.06%)

652 (90.18%)

0.013

Abnormal

238 (7.61%)

167 (6.94%)

71 (9.82%)

 

TG(mmol/L)*#

2.52 ± 1.86

2.45 ± 1.72

2.77 ± 2.24

< 0.001

Normal

1070 (34.20%)

848 (35.25%)

222 (30.71%)

0.027

Abnormal

2059 (65.80%)

1558 (64.75%)

501 (69.29%)

 

HDL-C(mmol/L)*

1.22 ± 0.28

1.22 ± 0.28

1.23 ± 0.31

0.441

Normal

2212 (70.69%)

1726 (71.74%)

486 (67.22%)

0.022

Abnormal

917 (29.31%)

680 (28.26%)

237 (32.8%)

 

Metabolic syndrome*

954(30.49%)

657(27.31%)

297(41.07%)

< 0.001

NFS*

   

<0.001

<-1.455

2114(67.56%)

1698 (70.57%)

416 (57.54%)

 

-1.455-0.676

949(30.33%)

670 (27.85%)

279 (38.58%)

 

≥ 0.676

66(2.11%)

38 (1.58%)

28 (3.87%)

Â